63 results
8-K
EX-99.1
VANI
Vivani Medical Inc
13 Jun 24
Other Events
8:01am
investigation of the safety, tolerability, and full pharmacokinetic profile of NPM-119 in patients with type 2 diabetes. LIBERATE-1 will enroll
8-K
EX-10.2
yy2uxet2eku qwd977
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
8-K
EX-10.1
s29nxdaly0 34einoahc
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
8-K
EX-99.1
x5f5m 08a1xkmbv
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
8-K
EX-99.1
zea7y 0o2nc
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.2
7bl6oj 6t0
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-3.2
ks6jiyw7
10 Jul 23
Material Modifications to Rights of Security Holders
4:04pm
8-K
EX-99.2
dxpgwgaw3j5n 8xa9
15 May 23
Results of Operations and Financial Condition
6:49am
DEFR14A
9sx2g1hiu5obc0gft6
1 May 23
Revised proxy
4:49pm
8-K
EX-10.1
1l020 fxvbu3imle4
28 Nov 22
Entry into a Material Definitive Agreement
5:29pm